A car struck two 13-year-old girls in Queens as they were crossing the street, killing one and injuring the other. The fatal accident took place on Oct. 24th at around 6:45 a.m. on Cross Bay Boulevard in Ozone Park. A green Chevy sedan, driven by a 55-year-old male, was headed south and struck the girls as they were crossing near 149th avenue.
The driver remained at the scene after the accident, Newsday reports. Police are still investigating the incident and have not made any arrests so far. The girls were transported to Jamaica Hospital Medical Center, where one girl was pronounced dead due to severe head trauma. The other girl suffered a leg injury and was reportedly in stable condition. Continue reading
Researchers at the Yale School of Public Health have identified a number of fracking chemicals that have the potential to cause cancer. The findings, published in the journal Science of the Total Environment, looked at compounds in fracking that can be released into the air and water, affecting nearby residents. Researchers were led by Nicole Deziel, Ph.D., assistant professor at Yale School of Public Health.
The researchers studied 1,000 chemicals used in fracking that can be released into the air or water. Dr. Deziel commented that this review of fracking chemicals is among the most inclusive. “Previous studies have examined the carcinogenicity of more selective lists of chemicals,” Deziel stated, according to an article posted on the Yale School of Public Health website. “To our knowledge, our analysis represents the most expansive review of carcinogenicity of hydraulic fracturing-related chemicals in the published literature.” Continue reading
On October 25, a Florida jury awarded $20 million in punitive damages against R.J. Reynolds Tobacco Co. in a trial over a chain smoker’s lung disease death. The jury added to the $8.8 million in compensatory damages awarded a day earlier.
Jurors awarded widower Alan Konzelman about $10 million more than he had sought, Law360 reports. He was awarded $8.8 million in compensatory damages for his pain and suffering over his wife’s death. He had asked for $5 million plus about $300,000 for his wife’s medical expenses. He had asked for $14 million in punitive damages and received $20 million. Continue reading
Teva Pharmaceuticals just received a “Warning Letter” from the U.S. Food and Drug Administration (FDA) due to the agency’s Current Good Manufacturing Practices (CGMP) inspection of Teva’s Gödöllő, Hungary’s manufacturing facility. Teva was also placed on Import Alert 66-40 on May 27, 2016.
The agency’s warning letter notes deficiencies in how manufacturing operations, laboratory controls, and Teva’s data integrity program are handled at the Gödöllő plant, according to Reuters. Continue reading
Lawsuits continue to be filed over Actos, a type 2 diabetes drug developed by Takeda and Eli Lilly. Plaintiffs in the litigation allege that Actos contributed to bladder cancer. Drug makers are accused of failing to disclose this risk to patients and their physicians. Court records indicate that a new Actos lawsuit was filed in June 2016.
The lawsuit, like others consolidated in the Actos multidistrict litigation (MDL) alleges that the plaintiff’s bladder cancer was a result of taking Actos. He alleges that the drug’s side effects ultimately led to economic damage due to medical bills and lost wages, mental and physical pain. The plaintiff took Actos for six years, according to the complaint.
At the time the June lawsuit was filed, the MDL contained over 4,500 lawsuits alleging Actos led to bladder cancer. MDLs are established when there are lawsuits with the same allegations. In order to make legal proceedings move quickly and efficiently, these lawsuits are centralized to one court before one judge. This consolidation helps eliminate duplicate discovery and conserves resources. In the Actos MDL, plaintiffs similarly allege that the manufacturers hid data linking Actos to bladder cancer. Continue reading
A study published in JAMA Oncology stated that androgen deprivation therapy (ADT), a standard treatment for men with prostate cancer, may raise the risk of dementia. The use of ADT has increased dramatically in the last few decades with as many as 500,000 men currently receiving ADT in the United States.
“ADT has a demonstrated survival benefit in some patients with prostate cancer. However, it also has been linked to several adverse health effects”, wrote study authors led by Dr. Kevin T. Nead of Stanford University School of Medicine in California. “A growing body of evidence supports a link between ADT and cognitive dysfunction, including Alzheimer disease.” Continue reading
Thirteen people were killed and 31 others were injured early Sunday morning, October 23, when the USA Holiday tour bus carrying them back from a casino near the Salton Sea crashed into a big rig truck near Palm Springs.
The passengers, many of whom were sleeping, had spent the night at the casino and were on the way back to Los Angeles when the crash occurred about 5:17 a.m., the Los Angeles Times reports. The bus slammed into the back of the truck’s trailer, crushing the front third of the bus. Most of those who died appeared to have been sitting toward the front of the bus. Continue reading
A talcum powder lawsuit is currently on trial in St. Louis, Missouri. The plaintiff in the lawsuit is a 63-year-old California woman who suffers from stage 4 ovarian cancer. She alleges that using talcum powder for feminine hygiene for 44 years has contributed to her cancer, and accuses J&J of failing to warn consumers.
J&J has attempted to have the trial postponed and dismissed. The company suffered significant losses earlier this year, when juries awarded verdicts of $72 million and $55 million to talcum powder plaintiffs. Court document show that J&J tried to postpone the trial, but the judge overseeing the litigation moved the case towards resolution. A week before the trial began, J&J tried to postpone the trial again by trying to move the case to federal court. This motion was also denied. Continue reading
Medtronic has announced that the U.S. Food and Drug Administration (FDA) has classified two global voluntary recalls of HeartWare International’s HeartWare Ventricular Assist Device (HVAD) as Class 1 recalls.
A class 1 recall is the FDA’s most serious recall category, reserved for situations where there is a reasonable risk of serious adverse health consequences or death.
The HVAD helps deliver blood from the heart to the rest of the body. A ventricular assist device is used in patients who are at risk of death from end-stage left ventricular heart failure and who are waiting for a heart transplant. The HVAD system includes a pump that is implanted in the space around the heart (pericardium) and a controller to regulate the speed and function of the pump.
Kraft Heinz is recalling its ready-to-eat “Lunchables Ham and American Cracker Stackers because it is misbranded and contains undeclared allergens, including wheat and soy. These ingredients, which can cause a life-threatening allergic reaction in some individuals, were not listed on the product label. According to an Oct. 9 recall alert posted on the U.S. Department of Agriculture website, the recall affects 959 pounds of packaged lunch products.
The recalled Lunchables were produced on Sept. 21, 2016. The products have a “USE BY” date of 25 DEC 2016 and production times ranging from 9:13 to 10:00 stamped on the side of the container, the alert states. Inside the USDA mark of inspection, consumers can locate the establishment number. Products affected by the recall have establishment number “EST. 537K”. The Lunchables were distributed to Utah and California. Continue reading